Prognostic value of Bcl‐2 in breast cancer patients treated with neoadjuvant anthracycline based chemotherapy

We have analyzed the predictive/prognostic value of Bcl‐2 protein in breast cancer patients treated with neoadjuvant chemotherapy. One hundred and ten patients were submitted to two different chemotherapeutic regimens: a) 5‐fluorouracil, adriamycin or epirubicin, and cyclophosphamide (FAC/FEC) durin...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Mol Oncol
Autori principali: Vargas-Roig, Laura M., Cuello-Carrión, F. Darío, Fernández-Escobar, Nicolás, Daguerre, Pedro, Leuzzi, Marcela, Ibarra, Jorge, Gago, Francisco E., Nadin, Silvina B., Ciocca, Daniel R.
Natura: Artigo
Lingua:Inglês
Pubblicazione: John Wiley and Sons Inc. 2008
Soggetti:
Papers
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5527786/
https://ncbi.nlm.nih.gov/pubmed/19383332
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.molonc.2008.01.004
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi